Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer Treatment

This study will address the prevalence of pre-therapeutic sarcopenia (PS) and its clinical impact during cancer treatment among adult cancer patients ≥ 18 years of age. A meta-analysis (MA) with random-effect models was performed via a MEDLINE systematic review, according to the PRISMA statement, fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Couderc, Anne-Laure, Liuu, Evelyne, Boudou-Rouquette, Pascaline, Poisson, Johanne, Frelaut, Maxime, Montégut, Coline, Mebarki, Soraya, Geiss, Romain, ap Thomas, Zoé, Noret, Aurélien, Pierro, Monica, Baldini, Capucine, Paillaud, Elena, Pamoukdjian, Frédéric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005339/
https://www.ncbi.nlm.nih.gov/pubmed/36904192
http://dx.doi.org/10.3390/nu15051193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005339/
https://www.ncbi.nlm.nih.gov/pubmed/36904192
http://dx.doi.org/10.3390/nu15051193

Ejemplares similares